#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal carcinoma Lupus nephritis Malignant glioma Vulval cancer recurrent Follicular lymphoma stage I Acute promyelocytic leukaemia Infantile spasms Ewing's sarcoma Haematological malignancy Hyperinsulinism Pulmonary alveolar haemorrhage Selective polysaccharide antibody deficiency Hyperphagia Primary biliary cholangitis Ovarian cancer stage IV More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Life with Disease Sarcoma – Life with Disease Hereditary neuropathic amyloidosis Glomerulonephritis rapidly progressive – Life with Disease Sjogren’s syndrome Lysosomal storage disorder Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Hypereosinophilic syndrome – Basic Information Pulmonary fibrosis – Treatment Skin angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methylprednisolone Acetate Zibotentan Octreotide Dcc-3116 Empasiprubart ACARBOSE [99MTC]PSMA I&S Cft1946 Glutenin DROSPIRENONE Doravirine Remifentanil Hydrochloride Clemizole Hydrochloride Fostemsavir Trometamol His203-Crm197 Ofatumumab Bi 764532 Enzalutamide IDOR-1117-2520C Vesleteplirsen More therapies…

    Learn about Your Condition

    Venous thrombosis limb Fibrosarcoma PIK3CA-activated mutation Brain stem glioma Epithelioid sarcoma HER2 negative breast cancer Synovitis Craniotomy Prodromal Alzheimer's disease Hyperhidrosis Hypophosphatasia Labour induction Urea cycle disorder Obstructive airways disorder Cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm

  • Study of INBRX-109 with Irinotecan Hydrochloride Trihydrate and Temozolomide for Patients with Advanced Solid Tumors, Including Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • 1,3-BUTYLENE GLYCOL
    • Cinchocaine Hydrochloride
    • Temozolomide
    France Italy The Netherlands Spain

  • Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Patritumab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +2

  • Safety Monitoring of Crizotinib for Patients Continuing from Previous Studies

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Crizotinib
    Italy

  • Study on 68Ga-FAPI-46 for Assessing Fibroblast Activation in Patients with Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Italy

  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Mdna11
    • Pembrolizumab
    Ireland Poland Portugal Spain

  • Study of AZD5863 for Adults with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Azd5863
    • Rilvegostomig
    • Tocilizumab
    France The Netherlands
Previous Page
1 … 7 8 9 10 11 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!